Implantable cardioverter defibrillators confer survival benefit in patients with renal insufficiency but not in dialysis-dependent patients.
Randomized clinical trials have demonstrated that the implantable cardioverter defibrillator (ICD) reduces mortality in heart failure patients with reduced systolic function but have excluded patients with advanced chronic kidney disease (CKD). We investigated the impact of ICDs on survival in patients with moderate-to-severe CKD, including those requiring dialysis therapy (DT). Patients followed at our institution between 1998 and 2008 with left ventricular ejection fraction (LVEF)< or =35% and CKD, defined as glomerular filtration rate (GFR) <60 mL/min, or who were on DT were identified from the medical record. The primary endpoint of all-cause death was analyzed by ICD status. A total of 78 patients (age=66+/-12 years, 73% men, EF=0.24+/-0.07, GFR 39+/-12 mL/min in those not on DT) of whom 32 had an ICD were followed for 2.7+/-2.3 years. In the DT (n=45) cohort, the presence of an ICD did not impact survival. In the CKD with no DT cohort (n=33), survival was significantly better in patients with an ICD (2-year survival 80% vs. 54%, p=0.027), and this benefit persisted after adjusting for gender, race, GFR, digoxin use, and presence of coronary disease, heart failure, or hypertension in a multivariate Cox regression model (odd ratio=0.23, adjusted p=0.028). Defibrillators improve survival in CKD patients with LVEF< or =35%, whereas patients requiring DT do not appear to extract such benefit. Further studies with larger number of patients are required to confirm these findings.
Khan
Faris
F
Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Adelstein
Evan
E
Saba
Samir
S
D000368:Aged; D016022:Case-Control Studies; D002423:Cause of Death; D016009:Chi-Square Distribution; D017147:Defibrillators, Implantable; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007676:Kidney Failure, Chronic / Q000401:mortality* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D016016:Proportional Hazards Models; D006435:Renal Dialysis / Q000401:mortality*; D012189:Retrospective Studies; D016019:Survival Analysis
Am J Nephrol. 2007;27(1):7-14
17204832
Nephrol Nurs J. 2009 Nov-Dec;36(6):613-9, 632
20050514
J Interv Card Electrophysiol. 2004 Dec;11(3):199-204
15548886
Pacing Clin Electrophysiol. 2007 Feb;30(2):207-13
17338717
Clin J Am Soc Nephrol. 2007 May;2(3):410-2
17699443
N Engl J Med. 2005 Jan 20;352(3):225-37
15659722
Kidney Int. 2005 Aug;68(2):818-25
16014061
N Engl J Med. 2002 Mar 21;346(12):877-83
11907286
Pacing Clin Electrophysiol. 2007 Sep;30(9):1091-5
17725751
Pacing Clin Electrophysiol. 2007 Mar;30(3):371-6
17367356
Kidney Int. 2006 May;69(10):1839-45
16508657
Hemodial Int. 2009 Jan;13(1):48-54
19210278
Am J Kidney Dis. 2003 Jan;41(1):1-12
12500213
Curr Med Res Opin. 2008 Aug;24(8):2151-7
18561878
Nephrol Dial Transplant. 2010 May;25(5):1596-604
20054025
N Engl J Med. 1996 Dec 26;335(26):1933-40
8960472
Heart Rhythm. 2006 Oct;3(10):1196-201
17018351
Am Heart J. 2006 Apr;151(4):852-6
16569548
Circulation. 2008 May 27;117(21):e350-408
18483207